Fuse Medical, Inc. announced the official distribution partnership with BRM Extremities S.r.l. (“BRM”) for the exclusive US national distribution of Silktoe® metatarsophalangeal joint arthroplasty implant. This is the latest addition to Fuse’s comprehensive portfolio of lower extremity products. Silktoe® offers patients with severe arthritis in the metatarsophalangeal joint another option outside of fusion. The design is derived from historical silastic toe arthroplasty devices and evolved to offer a more anatomical fit and replication of natural anatomical motion. The system consists of an elastomeric silicone spacer placed within each of the two bones comprising the metatarsophalangeal joint during toe arthroplasty and secured in place by titanium grommets. Available in five different sizes specific to the left or right foot, Silktoe® is sterile packaged and ready for implantation. Silktoe® is intended for arthroplasty of the first metatarsophalangeal joint (MTP1) of the foot. It represents a permanent implant, used in all severe forms of arthritis, such as: hallux rigidus or hallux limitus, painful rheumatoid arthritis, hallux abducto valgus associated with arthritis, or unstable or painful joint from previous surgery.